Purpose To examine the effect of delay in care on visual acuity (VA) in patients requiring
intravitreal injections (IVIs). Design Retrospective cohort study. Participants Patients 18 …

PURPOSE To determine the outcomes of intentionally suspending anti–vascular endothelial
growth factor (anti-VEGF) injections in eyes with advanced neovascular age-related macular …

Purpose: This study investigated the impact of baseline clinical and optical coherence
tomography (OCT) factors on the response to a 0.19-mg fluocinolone acetonide (FAc) …

Purpose We describe the large-scale self-initiated recruitment of patients to a self-monitoring
initiative for macular pathologic features during the coronavirus disease 2019 (COVID-19) …

The aim of the present study was to analyze the relationship of age-related macular
degeneration (AMD) progression with clinical characteristics, demographic, and …

Purpose To report on long-term real-life outcomes of anti-vascular endothelial growth factor
(anti-VEGF) therapy in neovascular age-related macular degeneration (nAMD) with optimal …

Purpose The long-term clinical outcome of adjuvant stereotactic radiotherapy (SRT) in
neovascular age-related macular degeneration (nAMD) patients was evaluated. Methods …

Background and objectives: To report the initial response to a single intravitreal
brolucizumab (IVI-B) injection in wet age-related macular degeneration (wAMD) or …

Background: Brolucizumab is a new anti-vascular endothelial growth factor (anti-VEGF) in
the treatment of neovascular age-related macular degeneration (nAMD) and idiopathic …

Die aktuell umfassenste GWAS zur Genetik der altersabhängigen Makuladegeneration
(AMD), einer komplexen progressiv-degenerativen Erkrankung der zentralen Netzhaut, fand …